Formulation

Apr 01, 2014
BioPharm International
By BioPharm International Editors
The presence of minute amounts of chelators can help minimize the degradation of monoclonal antibodies.
Mar 11, 2014
By BioPharm International Editors
HHS plan makes progress in ensuring availability of safe vaccines.
Jan 30, 2014
By BioPharm International Editors
NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes.
Jan 01, 2014
BioPharm International
By BioPharm International Editors
Antibody fragments pose unique challenges in recovery, purification, and formulation.
Dec 16, 2013
BioPharm International
Merck Serono fuels innovation with an integrated research, development, and manufacturing program and seed funding for startups.
Dec 16, 2013
BioPharm International
Clinical-stage biopharmaceutical company Ambrx leverages its site-specific bioconjugation technology through partnerships.
Oct 29, 2013
By BioPharm International Editors
GSK and the Gates Foundation will invest a combined $1.8 million in early stage research into vaccine thermostability.
Jul 25, 2013
The report highlights a need for greater third party certification to ensure GMP vigilance.
Jul 12, 2013
By BioPharm International Editors
The facility, which includes state-of-the-art formulation, analytical and synthetic laboratories as well as a customer training center, will focus on bioavailability enhancement and oral dosage formulations.
Mar 01, 2013
BioPharm International
Aggregate formation is influenced by multiple aspects of the bioproduction process but can be mitigated by good process design and control.
native1_300x100
lorem ipsum